**Core Concept**
The management of acute severe asthma involves the administration of medications that rapidly relieve bronchospasm and improve lung function. Short-acting beta-2 agonists (SABAs) are a critical component of acute asthma treatment due to their rapid onset of action and efficacy in relaxing bronchial smooth muscle.

**Why the Correct Answer is Right**
Short-acting beta-2 agonists, such as albuterol (salbutamol), work by stimulating beta-2 adrenergic receptors in the bronchial smooth muscle, leading to bronchodilation and improved airflow. This rapid relaxation of bronchial smooth muscle allows for increased airflow and symptom relief in patients with acute severe asthma. The onset of action for SABAs is typically within 5-15 minutes, making them ideal for acute asthma exacerbations.

**Why Each Wrong Option is Incorrect**
**Option B:** Long-acting beta-2 agonists (LABAs) are not suitable for acute severe asthma due to their slower onset of action and potential for adverse effects when used as monotherapy. LABAs are often used in combination with inhaled corticosteroids for long-term asthma control.
**Option C:** Oral theophylline has a slower onset of action and is not typically used as a first-line treatment for acute severe asthma. Theophylline is primarily used as an add-on therapy for patients who remain symptomatic despite treatment with inhaled corticosteroids and SABAs.
**Option D:** Inhaled ipratropium bromide is an anticholinergic agent that can be used as an adjunct therapy for acute severe asthma, but it is not the primary treatment. SABAs are more effective and rapidly acting than ipratropium bromide for relieving bronchospasm.

**Clinical Pearl / High-Yield Fact**
For acute severe asthma, the initial treatment should include a short-acting beta-2 agonist, such as albuterol, administered via a metered-dose inhaler (MDI) or a nebulizer. Patients should be instructed to use the MDI with a spacer to improve delivery and reduce side effects.

**✓ Correct Answer: A. Sho acting beta 2 agonists**